Travoprost

CAS No. 157283-68-6

Travoprost( Fluprostenol isopropyl ester | AL6221 | Flu-Ipr )

Catalog No. M20546 CAS No. 157283-68-6

Travoprost is used to treat glaucoma and ocular hypertensionis a potent and selective FP prostaglandin receptor agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 88 In Stock
5MG 81 In Stock
10MG 123 In Stock
25MG 185 In Stock
50MG 263 In Stock
100MG 384 In Stock
200MG 524 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Travoprost
  • Note
    Research use only, not for human use.
  • Brief Description
    Travoprost is used to treat glaucoma and ocular hypertensionis a potent and selective FP prostaglandin receptor agonist.
  • Description
    Travoprost is used to treat glaucoma and ocular hypertensionis a potent and selective FP prostaglandin receptor agonist.(In Vitro):Travoprost has sub-micromolar affinity for the DP, EP1, EP3, EP4, IP, and TP receptors.(In Vivo):Travoprost produces a lower incidence of ocular irritation than PGF20 isopropyl ester at a dose of 1 μg in the New Zealand albino (NZA) rabbit. Topical ocular application of Travoprost produces a marked miotic effect in cats following doses of 0.01, 0.03 and 0.1 μg. In the ocular hypertensive monkey, b.i.d. application of 0.1 and 0.3 μg of travoprost afforded peak reduction in intraocular pressure (IOP) of 22.7% and 28.6%, respectively. Topical application of travoprost was well tolerated in rabbits, cats and monkeys, causing no ocular irritation or discomfort at doses up to 1 μg.
  • In Vitro
    Travoprost has sub-micromolar affinity for the DP, EP1, EP3, EP4, IP, and TP receptors.
  • In Vivo
    Travoprost produces a lower incidence of ocular irritation than PGF20 isopropyl ester at a dose of 1 μg in the New Zealand albino (NZA) rabbit. Topical ocular application of Travoprost produces a marked miotic effect in cats following doses of 0.01, 0.03 and 0.1 μg. In the ocular hypertensive monkey, b.i.d. application of 0.1 and 0.3 μg of travoprost afforded peak reduction in intraocular pressure (IOP) of 22.7% and 28.6%, respectively. Topical application of travoprost was well tolerated in rabbits, cats and monkeys, causing no ocular irritation or discomfort at doses up to 1 μg.
  • Synonyms
    Fluprostenol isopropyl ester | AL6221 | Flu-Ipr
  • Pathway
    GPCR/G Protein
  • Target
    Prostaglandin Receptor
  • Recptor
    Prostaglandin Receptor
  • Research Area
    Others
  • Indication
    open-angle glaucoma or ocular hypertension

Chemical Information

  • CAS Number
    157283-68-6
  • Formula Weight
    500.55
  • Molecular Formula
    C26H35F3O6
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:41.67 mg/mL (83.25 mM)
  • SMILES
    CC(C)OC(=O)CCC\C=C/CC1C(O)CC(O)C1\C=C\C(O)COc1cccc(c1)C(F)(F)F
  • Chemical Name
    propan-2-yl (Z)-7-[(1R2R3R5S)-35-dihydroxy-2-[(E3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hellberg M R Sallee V L Mclaughlin M A et al. Preclinical Efficacy of Travoprost a Potent and Selective FP Prostaglandin Receptor Agonist[J]. Journal of Ocular Pharmacology and Therapeutics 2001 17(5):421-432.
molnova catalog
related products
  • MK-1029

    ADC-3680 is a potent, selective prostaglandin D2 receptor (DP2, CRTH2) antagonist for the treatment of asthma.

  • Cloprostenol sodium

    Cloprostenol sodium is a more water solute crystalline form of cloprostenol than the free acid is a synthetic analog of prostaglandin F2α.

  • (+)-Fluprostenol

    (+)-Fluprostenol, an analogue of prostaglandin F2 alpha, is a prostaglandin F2α receptor PTGFR agonist and decreases the expression of Oviductal glycoprotein 1 (OVGP1).